About this trial
Current evidence and clinical applications of robotic gait training devices for motor function recovery post-stroke are increasingly available. Although existing research demonstrates that robotic gait training can improve patients' gait and balance, there remains a lack of in-depth investigation into its specific mechanisms of action concerning central nervous system (CNS) reorganization - notably, changes in activity within the motor cortex and associated neural networks. The intrinsic changes within the CNS have received insufficient attention, limiting a comprehensive and profound understanding of the rehabilitation outcomes. Therefore, this study aims to elucidate the potential mechanisms underlying robotic gait training-induced neuroplasticity by integrating functional near-infrared spectroscopy (fNIRS) technology with multi-dimensional lower limb motor function assessment tools (such as FAC, BBS, AMEDA, 10MWT, 6MWT, TUGT). It will systematically investigate the effects of robotic gait training on both the central nervous system and lower limb motor function in stroke patients. Furthermore, the study will compare the differences in functional recovery efficacy between robotic gait training and conventional rehabilitation therapies.
Eligibility criteria
Qualifiers
Patients or family gave written informed consents to participate in this study.
Patients with first hemiplegia caused by primary supratentorial intracerebral hemorrhage or cerebral infarction.
Within 1 year of stroke onset
Aged ≥ 20
Disqualifiers
A history of myocardial infarction
Muscular or neurological disorder including diabetic neuropathy
Symptomatic angina or arrhythmia
Symptomatic respiratory disorder
Trial design
Treatments tested in this trial
- welwalk training
- physical therapy